Global X CleanTech ETF (CTEC) Quote

Need a good honest company first before getting what you call good investors....and axxa ain't it....they have shown their colors and resembles red flags...not green $ signs

🔥🔥🔥500 BILLION FOR THE CURE TO CANCER M-RNA VACCINE🔥🔥🔥

If jurisdiction was an issue, XTI's lawyers would have brought it as a reason for dismissal previously. Maybe they did -- and the judge already ruled against them. Either way, it's very doubtful it's still an issue in this case.

but you follow the penny stocks why

What about 500k down payement for mt.Vernon?

I don't invest in scams.

me:



the ban on outgoing messaging from federal agencies should surprise no one. the new administration won this cycle by emphasizing it was time for changes in defense to state to homeland security to treasury to healthcare.meta and data; meta data.
of course

I believe there is an authorized generic for OxyContin, but that's not quite the same. Once generics are approved the market price will tank, just like Vyvanse will. If Elite were the only one to get the approval that is one thing, but it is not the case. Buying Elite would not stop OxyContin pricin

Charlie Rich * Rollin' with the Flow 1977 HQ

[yt]b9_7ByKnwWY[/yt]

https://www.youtube.com/watch?v=b9_7ByKnwWY

You're wrong. That's why you hide behind "probably."

Good idea, moms. We have both MNMD and PFE in our portfolios. PFE's expensive acquisition of SGEN(very profitable for us) has been slow to bring enough revenue to the balance sheet to solve PFE's problem being termed a laggard in pharma-land. HLS in Canada terminated a contract with PFE that involve

Next leg up wide open $weet$$

Good Afternoon-- catching up on the posts!

You don't even know the difference between "knew" and "new," I knew it!

RAIL
https://investorshub.advfn.com/uimage/uploads/2025/1/25/zlxqsIMG_4814.gif

Be careful the bird like sitting on high voltage lines lol.

Selection issues for an OLE are many.

There are the drop outs from the original trial. That selects against those who can not tolerate the drug or the titration rate.
There are those that don't choose to go into the OLE for whatever reason. That is self selection.
There

Once again, you are absolutely incorrect. But at least you are consistent.

Do you interpret that as a good thing or a bad thing? Do you think they're being ominous and distressful to investors or cooking up something good for all?

I hope so. Sometime this year.

are you actualy invest in BMXI or is this just boad you can talk on

The financial advisor was advised by the insider to buy the shares but that conversation was kept secret. Insider advising the financial advisor is more likely.

BIEL: VAGUS NERVE PATENT (PENDING)
NY Post - Jan. 23, 2025
Implantable vagus nerve stimulation (VNS) devices, which can cost $50,000, have long been used to treat epilepsy, depression and stroke. That’s because jolting the vagus nerve — the longest cranial nerve in the body — can help

MESO
https://investorshub.advfn.com/uimage/uploads/2025/1/25/rkzrzIMG_4813.gif